Sessa Capital IM, L.P.
Net seller this quarter
$5.98B
26
-$820M
83.8%
Holdings
| Company | Value | % of portfolio | % of company | POSITION CHANGE qoq % | First reported |
|---|---|---|---|---|---|
| Q2 2026 | |||||
 HUM | $1.48B | 24.76% | 3.10% | Not reported | Q4 2024 |
 WBD | $804M | 13.45% | 1.20% | -5.6% | Q2 2022 |
 KMB | $572M | 9.57% | 1.57% | +17.6% | Q1 2026 |
 SHC | $480M | 8.03% | 9.49% | +17.4% | Q1 2024 |
 PCG | $413M | 6.91% | 1.12% | Not reported | Q4 2017 |
 ALLY | $390M | 6.52% | 2.79% | Not reported | Q4 2014 |
 COF | $313M | 5.23% | 0.25% | Not reported | Q2 2025 |
 ILMN | $197M | 3.29% | 0.74% | -65.9% | Q2 2025 |
 TFX | $193M | 3.24% | 3.45% | Not reported | Q1 2026 |
 MICC | $167M | 2.79% | 1.57% | +100.9% | Q4 2025 |
 GRAL | $139M | 2.33% | 4.56% | +18.5% | Q2 2024 |
 AXTA | $121M | 2.03% | 1.65% | +59.2% | Q2 2020 |
 CPNG | $90.2M | 1.51% | Not reported | Not reported | Q1 2026 |
 FTRE | $79.9M | 1.34% | 4.83% | Not reported | Q3 2023 |
 TNDM | $77M | 1.29% | 7.33% | +7.8% | Q1 2023 |
| ASA | $54.6M | 0.91% | Not reported | Not reported | Q1 2024 |
 ROKU | $48.3M | 0.81% | 0.24% | Not reported | Q1 2024 |
 LXRX | $45.5M | 0.76% | 4.24% | +5.9% | Q2 2025 |
 MMED | $29.9M | 0.50% | 0.71% | Not reported | Q1 2026 |
 CMCSA | $25.7M | 0.43% | 0.03% | New | Q2 2026 |
 SENS | $25.2M | 0.42% | 8.39% | +151.3% | Q1 2026 |
 RNA | $20.2M | 0.34% | 8.77% | +172.0% | Q1 2026 |
 SABS | $8.57M | 0.14% | 2.63% | Not reported | Q4 2023 |
 BALY | $6.14M | 0.10% | 0.91% | Not reported | Q3 2023 |
 FLG | $480K | 0.01% | 0.01% | Not reported | Q3 2024 |
 BHR | $56.1K | 0.00% | 0.04% | Not reported | Q2 2018 |
| Q1 2026 | |||||
| WBD | $878M | 15.94% | 1.28% | -29.9% | Q2 2022 |
| HUM | $646M | 11.73% | 3.10% | +60.8% | Q4 2024 |
| PCG | $432M | 7.84% | 1.12% | Not reported | Q4 2017 |
| KMB | $427M | 7.76% | 1.34% | New | Q1 2026 |
| ILMN | $404M | 7.33% | 2.14% | -3.8% | Q2 2025 |
 APD | $344M | 6.25% | 0.53% | Not reported | Q2 2025 |
| ALLY | $333M | 6.05% | 2.76% | +81.3% | Q4 2014 |
| SHC | $331M | 6.00% | 8.11% | +12.2% | Q1 2024 |
| COF | $284M | 5.16% | 0.25% | Not reported | Q2 2025 |
 SOLS | $214M | 3.88% | 1.77% | -62.4% | Q4 2025 |
| TFX | $183M | 3.31% | 3.45% | New | Q1 2026 |
 FTAI | $98M | 1.78% | 0.39% | Not reported | Q1 2025 |
| CPNG | $98M | 1.78% | Not reported | New | Q1 2026 |
| TNDM | $90.7M | 1.65% | 6.91% | -5.4% | Q1 2023 |
| GRAL | $88.9M | 1.61% | 4.18% | +371.4% | Q2 2024 |
| MICC | $71.4M | 1.30% | 0.78% | Not reported | Q4 2025 |
| ASA | $65.1M | 1.18% | Not reported | Not reported | Q1 2024 |
| AXTA | $61.6M | 1.12% | 1.04% | +11.5% | Q2 2020 |
| FTRE | $43.3M | 0.79% | 4.86% | +15.0% | Q3 2023 |
| ROKU | $33.1M | 0.60% | 0.24% | Not reported | Q1 2024 |
| MMED | $29.8M | 0.54% | Not reported | New | Q1 2026 |
| LXRX | $27.9M | 0.51% | 4.21% | +497.1% | Q2 2025 |
 PFGC | $24.1M | 0.44% | 0.18% | -52.0% | Q3 2025 |
| SENS | $11.8M | 0.21% | 4.23% | New | Q1 2026 |
 USFD | $10.2M | 0.19% | 0.05% | -75.2% | Q4 2022 |
| SABS | $8.42M | 0.15% | 2.90% | Not reported | Q4 2023 |
| RNA | $7.37M | 0.13% | 3.22% | New | Q1 2026 |
 OSCR | $5.74M | 0.10% | Not reported | Not reported | Q2 2025 |
| BALY | $4.32M | 0.08% | 0.91% | Not reported | Q3 2023 |
| FLG | $423K | 0.01% | 0.01% | Not reported | Q3 2024 |
| BHR | $61.2K | 0.00% | 0.04% | Not reported | Q2 2018 |
| Q4 2025 | |||||
| WBD | $1.31B | 24.55% | 1.84% | -10.0% | Q2 2022 |
| HUM | $594M | 11.10% | 1.93% | +4.8% | Q4 2024 |
| ILMN | $446M | 8.35% | 2.22% | -27.4% | Q2 2025 |
| PCG | $395M | 7.38% | 1.12% | Not reported | Q4 2017 |
| COF | $378M | 7.06% | 0.25% | -13.9% | Q2 2025 |
| SOLS | $363M | 6.78% | 4.70% | New | Q4 2025 |
| SHC | $363M | 6.78% | 7.23% | +107.2% | Q1 2024 |
| APD | $293M | 5.47% | 0.53% | +33.0% | Q2 2025 |
| ALLY | $212M | 3.96% | 1.52% | Not reported | Q4 2014 |
| TNDM | $110M | 2.05% | 7.32% | Not reported | Q1 2023 |
| FTAI | $78.7M | 1.47% | 0.39% | Not reported | Q1 2025 |
| MICC | $75.6M | 1.41% | 0.78% | New | Q4 2025 |
| FTRE | $68.9M | 1.29% | 4.29% | Not reported | Q3 2023 |
| AXTA | $64.4M | 1.20% | 0.93% | Not reported | Q2 2020 |
| ASA | $62.7M | 1.17% | Not reported | Not reported | Q1 2024 |
| PFGC | $52.7M | 0.99% | 0.38% | +96.7% | Q3 2025 |
| ROKU | $38M | 0.71% | 0.24% | Not reported | Q1 2024 |
| USFD | $33.6M | 0.63% | 0.20% | -43.0% | Q4 2022 |
| GRAL | $31.2M | 0.58% | 0.90% | -53.6% | Q2 2024 |
 MRNA | $21.9M | 0.41% | 0.19% | Not reported | Q1 2025 |
| THS | $11M | 0.21% | 0.93% | -88.9% | Q1 2024 |
| SABS | $8.22M | 0.15% | 4.62% | Not reported | Q4 2023 |
| BALY | $7.4M | 0.14% | 0.92% | +367.3% | Q3 2023 |
| OSCR | $7.19M | 0.13% | Not reported | Not reported | Q2 2025 |
| LXRX | $3.45M | 0.06% | 0.82% | Not reported | Q2 2025 |
| FLG | $404K | 0.01% | 0.01% | Not reported | Q3 2024 |
| BHR | $74.5K | 0.00% | 0.04% | Not reported | Q2 2018 |
| Q3 2025 | |||||
| WBD | $989M | 23.40% | 2.04% | Not reported | Q2 2022 |
| HUM | $576M | 13.63% | 1.84% | +4.2% | Q4 2024 |
| ILMN | $445M | 10.53% | 3.05% | -0.8% | Q2 2025 |
| COF | $385M | 9.11% | 0.28% | Not reported | Q2 2025 |
| PCG | $371M | 8.77% | 1.12% | Not reported | Q4 2017 |
| APD | $243M | 5.76% | 0.40% | +35.3% | Q2 2025 |
| ALLY | $184M | 4.34% | 1.52% | Not reported | Q4 2014 |
| SHC | $156M | 3.69% | 3.49% | +57.4% | Q1 2024 |
| THS | $84.9M | 2.01% | 8.32% | Not reported | Q1 2024 |
| FTAI | $66.7M | 1.58% | 0.39% | Not reported | Q1 2025 |
 ZBRA | $61.5M | 1.46% | 0.41% | Not reported | Q2 2024 |
 KDP | $61.2M | 1.45% | 0.18% | New | Q3 2025 |
| TNDM | $60.7M | 1.44% | 7.38% | Not reported | Q1 2023 |
| USFD | $59.9M | 1.42% | 0.35% | +95.3% | Q4 2022 |
| ASA | $48.1M | 1.14% | Not reported | Not reported | Q1 2024 |
| GRAL | $46.5M | 1.10% | 2.17% | Not reported | Q2 2024 |
| ROKU | $35M | 0.83% | 0.24% | Not reported | Q1 2024 |
| FTRE | $33.6M | 0.80% | 4.33% | Not reported | Q3 2023 |
| PFGC | $31M | 0.73% | 0.19% | New | Q3 2025 |
| MRNA | $19.2M | 0.45% | 0.19% | Not reported | Q1 2025 |
| OSCR | $9.47M | 0.22% | Not reported | Not reported | Q2 2025 |
| SABS | $4.42M | 0.10% | 4.63% | +379.5% | Q4 2023 |
 T | $4.06M | 0.10% | 0.00% | Not reported | Q2 2021 |
| LXRX | $4.05M | 0.10% | 0.82% | Not reported | Q2 2025 |
| BALY | $1.06M | 0.03% | 0.20% | Not reported | Q3 2023 |
| FLG | $371K | 0.01% | 0.01% | Not reported | Q3 2024 |
| BHR | $70.8K | 0.00% | 0.04% | Not reported | Q2 2018 |